Pharma Packaging Films Market: Barrier Materials, Blisters and Growth Trends

A tablet's effectiveness depends not only on its formulation but also on its packaging. Moisture, oxygen, light and contamination can all degrade medicines before they reach patients. Pharmaceutical packaging films are the thin but highly engineered materials that form blister packs, sachets, pouches and lidding that protect drugs throughout their shelf life. The pharma packaging films market is growing alongside global medicine consumption, stricter quality requirements and a strong push for more sustainable packaging.

This article explains the main film types, key growth figures, demand drivers, sustainability trends and the outlook for the market.

Key Takeaways

• The global packaging films market is projected to grow from USD 110.52 billion in 2024 to USD 157.86 billion by 2030, a 6.25% CAGR, according to Actual Market Research.
• The global blister packaging market was valued at more than USD 34.39 billion in 2024 and is expected to exceed USD 49.35 billion by 2030 at a 6.36% CAGR.
• The pharmaceutical industry is the largest consumer of plastic medical packaging.
• High-barrier performance, patient safety and recyclability are the defining trends.

What Are Pharma Packaging Films?

Pharma packaging films are plastic, aluminium or multi-layer laminate materials used to package medicines. Their main jobs are to:

• Create a barrier against moisture, oxygen and light that could degrade active ingredients.
• Protect patients through tamper evidence and, where needed, child resistance.
• Enable unit-dose packaging so each tablet or capsule is protected until use.
• Carry information such as batch numbers, expiry dates and dosing instructions.

Main Types of Pharmaceutical Films

PVC Films

Polyvinyl chloride is the traditional workhorse for thermoformed blister cavities. It is clear, easy to form and cost-effective, but offers only moderate moisture protection on its own.

PVDC-Coated Films

Coating PVC with polyvinylidene chloride significantly improves the moisture and oxygen barrier, making it suitable for more sensitive products.

High-Barrier Fluoropolymer Laminates

Laminates using fluoropolymer layers offer some of the highest moisture barriers available in transparent films, used for highly moisture-sensitive drugs.

Cold-Form Aluminium (Alu-Alu)

Aluminium-based laminates formed without heat provide a near-total barrier to moisture, oxygen and light. They are used for the most sensitive medicines, though they are opaque and larger in format.

Polyolefin and PET Films

Polypropylene, polyethylene and PET films are gaining attention as alternatives to PVC because they can support more recyclable, mono-material designs.

Lidding Foils

Aluminium or paper-based lidding seals the blister and provides push-through or peelable access.

Market Size and Related Segments

According to Actual Market Research, the global packaging films market is set to grow from USD 110.52 billion in 2024 to USD 157.86 billion by 2030, a 6.25% CAGR. While food packaging accounts for the largest share overall, healthcare and pharmaceutical applications demand the most technically advanced, high-barrier films.

Blister packaging is the main destination for pharma films. The global blister packaging market was valued at more than USD 34.39 billion in 2024 and is expected to exceed USD 49.35 billion by 2030, growing at a 6.36% CAGR. Plastic is the largest material segment thanks to its durability, cost efficiency and adaptability, and carded blister types are the largest format segment.

The wider global plastic medical packaging market is anticipated to grow at more than 6.2% CAGR from 2025 to 2030, with the pharmaceutical industry as its largest consumer. Packaging equipment is growing too: the global automatic pharmaceutical packaging machine market is anticipated to grow at more than 7.1% CAGR from 2025 to 2030.

Growth Drivers

Rising Medicine Consumption

Ageing populations, the growing burden of chronic disease and expanding healthcare access in emerging markets increase demand for medicines and, with it, their packaging.

Moisture-Sensitive and Complex Drugs

Many modern formulations are sensitive to moisture and oxygen, which drives demand for high-barrier films and aluminium-based solutions.

Unit-Dose and Patient Adherence

Blister packs make it easier for patients to follow dosing schedules and for pharmacists and hospitals to manage medications safely.

Regulatory and Safety Requirements

Requirements for tamper evidence, child resistance, serialisation and track-and-trace systems add value to advanced packaging solutions.

Industry Consolidation

Large deals are reshaping the supply base. Amcor's all-stock acquisition of Berry Global, valued at USD 8.4 billion, brought together two major flexible and rigid packaging players and strengthened their position in pharmaceutical and healthcare packaging.

Sustainability: The Defining Trend

Pharmaceutical packaging faces growing pressure to reduce its environmental footprint. Traditional blister packs combine PVC and aluminium, which are difficult to separate and recycle. In response, the industry is developing:

• PVC-free blister films based on polypropylene or PET.
• Mono-material designs that are easier to recycle.
• Thinner, lighter films that reduce material use without compromising protection.
• Recycled and bio-based content where regulations allow.

Global policy discussions on plastic production and recycling are adding urgency. Packaging machine manufacturers are also adapting equipment to handle biodegradable and lower-plastic materials. The challenge is to achieve sustainability without weakening the barrier properties and safety that medicines require, and any material change must pass stability testing and regulatory approval.

How Pharmaceutical Companies Choose Packaging Films

Selecting a film is a technical and regulatory decision, not just a purchasing one. Key criteria include:

• Barrier requirement: the moisture and oxygen protection needed, based on stability testing.
• Product format: tablet or capsule size, which affects cavity design and film thickness.
• Machine compatibility: how well the film runs on existing thermoforming or cold-forming lines.
• Regulatory history: materials with established approvals reduce qualification risk.
• Total cost: film price, yield, line speed and pack size together.
• Sustainability targets: recyclability and material reduction goals.

Regional Outlook

North America has a mature, highly competitive market supported by a well-established pharmaceutical sector and rapid drug development. Europe leads on sustainability regulation and recyclable packaging innovation. Asia-Pacific is a fast-growing region as countries such as China, India, South Korea and Japan modernise healthcare systems and invest in domestic pharmaceutical manufacturing. Latin America and the Middle East & Africa offer growth as healthcare access improves.

Challenges

• Balancing barrier performance with recyclability.
• Long qualification timelines for changing packaging materials.
• Raw material price volatility for polymers and aluminium.
• Strict quality and regulatory requirements that raise entry barriers for new suppliers.

Opportunities

• Recyclable high-barrier films that can replace PVC-aluminium combinations.
• Packaging for biologics, speciality drugs and temperature-sensitive products.
• Smart packaging features that support adherence and authentication.
• Local film production to serve fast-growing pharmaceutical hubs in Asia-Pacific.

Strategic Recommendations

• For film producers: invest in recyclable high-barrier solutions and support customers with stability data to ease qualification.
• For pharmaceutical companies: plan packaging transitions early, as material changes require testing and regulatory review.
• For converters: expand capacity close to fast-growing pharmaceutical manufacturing hubs in Asia-Pacific.

Frequently Asked Questions

What films are used in pharmaceutical packaging?

Common films include PVC, PVDC-coated PVC, fluoropolymer laminates, cold-form aluminium, polypropylene, PET and aluminium lidding foils.

How big is the blister packaging market?

According to Actual Market Research, the global blister packaging market was valued at more than USD 34.39 billion in 2024 and is expected to exceed USD 49.35 billion by 2030.

Why are barrier properties important in pharma packaging?

Moisture, oxygen and light can degrade active ingredients, reducing a medicine's effectiveness and shelf life.

Is pharmaceutical packaging becoming more sustainable?

Yes. The industry is developing PVC-free, mono-material and thinner films, though any change must maintain protection and pass regulatory approval.

How fast is the plastic medical packaging market growing?

Actual Market Research expects the global plastic medical packaging market to grow at more than 6.2% CAGR from 2025 to 2030.

Conclusion

Pharma packaging films play a critical role in protecting medicines and patients. Steady growth in medicine consumption, demanding new formulations and the shift towards sustainable materials will keep this market evolving. Explore Actual Market Research's packaging reports or contact us for tailored insights.